The global Melanoma Skin Cancer Diagnostic Testing market is projected to grow from US$ 767 million in 2024 to US$ 1210.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.9% during the forecast period.

Melanoma Skin Cancer Diagnostic Testing Market

Melanoma skin cancer is the most dangerous type of skin cancer. Development of defective DNA due to exposure to the ultraviolet radiation from sunlight or tanning beds leads to develop melanoma skin cancer. This genetic defect triggers mutation in the cell structure resulting in rapid multiplication of cells forming a malignant tumor. These malignant tumors often originate at basal layer of epidermis which produces melanocyte type of pigment which makes most of melanoma skin cancer black or brown in color. As per skin cancer foundation, in 2018 around 178,560 cases of melanoma will be diagnosed in United States alone. Melanoma skin cancer is the least common type of skin cancer and it is curable if diagnosed early. Early melanoma skin cancer diagnostic testing plays major role future treatment regimen and possible cure for the patient.

Market Analysis and Insights: Global Melanoma Skin Cancer Diagnostic Testing Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Melanoma Skin Cancer Diagnostic Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Melanoma Skin Cancer Diagnostic Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Melanoma Skin Cancer Diagnostic Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Melanoma Skin Cancer Diagnostic Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Melanoma Skin Cancer Diagnostic Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Melanoma Skin Cancer Diagnostic Testing revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Melanoma Skin Cancer Diagnostic Testing Market Report

Report Metric	Details
Report Name	Melanoma Skin Cancer Diagnostic Testing Market
Accounted market size in 2024	US$ 767 in million
Forecasted market size in 2030	US$ 1210.4 million
CAGR	7.9
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Biopsy Imaging Others
Segment by Application	Hospitals Dermatology Clinics Diagnostic Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, Cancer Genetics, Castle Biosciences, NeoGenomics, Dermtech, Sysmex Inostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Melanoma Skin Cancer Diagnostic Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Melanoma Skin Cancer Diagnostic Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Melanoma Skin Cancer Diagnostic Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Melanoma Skin Cancer Diagnostic Testing Market growing?

Ans: The Melanoma Skin Cancer Diagnostic Testing Market witnessing a CAGR of 7.9 during the forecast period 2024-2030.

What is the Melanoma Skin Cancer Diagnostic Testing Market size in 2030?

Ans: The Melanoma Skin Cancer Diagnostic Testing Market size in 2030 will be US$ 1210.4 million.

Who are the main players in the Melanoma Skin Cancer Diagnostic Testing Market report?

Ans: The main players in the Melanoma Skin Cancer Diagnostic Testing Market are Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, Cancer Genetics, Castle Biosciences, NeoGenomics, Dermtech, Sysmex Inostics

What are the Application segmentation covered in the Melanoma Skin Cancer Diagnostic Testing Market report?

Ans: The Applications covered in the Melanoma Skin Cancer Diagnostic Testing Market report are Hospitals, Dermatology Clinics, Diagnostic Laboratories, Others

What are the Type segmentation covered in the Melanoma Skin Cancer Diagnostic Testing Market report?

Ans: The Types covered in the Melanoma Skin Cancer Diagnostic Testing Market report are Biopsy, Imaging, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Biopsy

1.2.3 Imaging

1.2.4 Others

1.3 Market by Application

1.3.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Dermatology Clinics

1.3.4 Diagnostic Laboratories

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Melanoma Skin Cancer Diagnostic Testing Market Perspective (2019-2030)

2.2 Global Melanoma Skin Cancer Diagnostic Testing Growth Trends by Region

2.2.1 Melanoma Skin Cancer Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Region (2019-2024)

2.2.3 Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Region (2025-2030)

2.3 Melanoma Skin Cancer Diagnostic Testing Market Dynamics

2.3.1 Melanoma Skin Cancer Diagnostic Testing Industry Trends

2.3.2 Melanoma Skin Cancer Diagnostic Testing Market Drivers

2.3.3 Melanoma Skin Cancer Diagnostic Testing Market Challenges

2.3.4 Melanoma Skin Cancer Diagnostic Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Melanoma Skin Cancer Diagnostic Testing by Players

3.1.1 Global Melanoma Skin Cancer Diagnostic Testing Revenue by Players (2019-2024)

3.1.2 Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Players (2019-2024)

3.2 Global Melanoma Skin Cancer Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Melanoma Skin Cancer Diagnostic Testing Market Concentration Ratio

3.4.1 Global Melanoma Skin Cancer Diagnostic Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Melanoma Skin Cancer Diagnostic Testing Revenue in 2023

3.5 Global Key Players of Melanoma Skin Cancer Diagnostic Testing Head office and Area Served

3.6 Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Product and Application

3.7 Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Melanoma Skin Cancer Diagnostic Testing Breakdown Data by Type

4.1 Global Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Type (2019-2024)

4.2 Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Type (2025-2030)

5 Melanoma Skin Cancer Diagnostic Testing Breakdown Data by Application

5.1 Global Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Application (2019-2024)

5.2 Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Melanoma Skin Cancer Diagnostic Testing Market Size (2019-2030)

6.2 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type

6.2.1 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2019-2024)

6.2.2 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2025-2030)

6.2.3 North America Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2019-2030)

6.3 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application

6.3.1 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2019-2024)

6.3.2 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2025-2030)

6.3.3 North America Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2019-2030)

6.4 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country

6.4.1 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2019-2024)

6.4.3 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Melanoma Skin Cancer Diagnostic Testing Market Size (2019-2030)

7.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type

7.2.1 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2019-2024)

7.2.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2025-2030)

7.2.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2019-2030)

7.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application

7.3.1 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2019-2024)

7.3.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2025-2030)

7.3.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2019-2030)

7.4 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country

7.4.1 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2019-2024)

7.4.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Melanoma Skin Cancer Diagnostic Testing Market Size (2019-2030)

8.2 China Melanoma Skin Cancer Diagnostic Testing Market Size by Type

8.2.1 China Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2019-2024)

8.2.2 China Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2025-2030)

8.2.3 China Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2019-2030)

8.3 China Melanoma Skin Cancer Diagnostic Testing Market Size by Application

8.3.1 China Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2019-2024)

8.3.2 China Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2025-2030)

8.3.3 China Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Melanoma Skin Cancer Diagnostic Testing Market Size (2019-2030)

9.2 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type

9.2.1 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2019-2024)

9.2.2 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2025-2030)

9.2.3 Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2019-2030)

9.3 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application

9.3.1 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2019-2024)

9.3.2 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2025-2030)

9.3.3 Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2019-2030)

9.4 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region

9.4.1 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2019-2024)

9.4.3 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type

10.2.1 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application

10.3.1 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country

10.4.1 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Myriad Genetics

11.1.1 Myriad Genetics Company Details

11.1.2 Myriad Genetics Business Overview

11.1.3 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Introduction

11.1.4 Myriad Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

11.1.5 Myriad Genetics Recent Developments

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Details

11.2.2 Abbott Laboratories Business Overview

11.2.3 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Introduction

11.2.4 Abbott Laboratories Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

11.2.5 Abbott Laboratories Recent Developments

11.3 Foundation Medicine

11.3.1 Foundation Medicine Company Details

11.3.2 Foundation Medicine Business Overview

11.3.3 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Introduction

11.3.4 Foundation Medicine Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

11.3.5 Foundation Medicine Recent Developments

11.4 Pathway Genomics Corporation

11.4.1 Pathway Genomics Corporation Company Details

11.4.2 Pathway Genomics Corporation Business Overview

11.4.3 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Introduction

11.4.4 Pathway Genomics Corporation Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

11.4.5 Pathway Genomics Corporation Recent Developments

11.5 Cancer Genetics

11.5.1 Cancer Genetics Company Details

11.5.2 Cancer Genetics Business Overview

11.5.3 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Introduction

11.5.4 Cancer Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

11.5.5 Cancer Genetics Recent Developments

11.6 Castle Biosciences

11.6.1 Castle Biosciences Company Details

11.6.2 Castle Biosciences Business Overview

11.6.3 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Introduction

11.6.4 Castle Biosciences Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

11.6.5 Castle Biosciences Recent Developments

11.7 NeoGenomics

11.7.1 NeoGenomics Company Details

11.7.2 NeoGenomics Business Overview

11.7.3 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Introduction

11.7.4 NeoGenomics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

11.7.5 NeoGenomics Recent Developments

11.8 Dermtech

11.8.1 Dermtech Company Details

11.8.2 Dermtech Business Overview

11.8.3 Dermtech Melanoma Skin Cancer Diagnostic Testing Introduction

11.8.4 Dermtech Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

11.8.5 Dermtech Recent Developments

11.9 Sysmex Inostics

11.9.1 Sysmex Inostics Company Details

11.9.2 Sysmex Inostics Business Overview

11.9.3 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Introduction

11.9.4 Sysmex Inostics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

11.9.5 Sysmex Inostics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Myriad Genetics

Abbott Laboratories

Foundation Medicine

Pathway Genomics Corporation

List of Tables

Table 1. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Biopsy

Table 3. Key Players of Imaging

Table 4. Key Players of Others

Table 5. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2019-2024)

Table 9. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2025-2030)

Table 11. Melanoma Skin Cancer Diagnostic Testing Market Trends

Table 12. Melanoma Skin Cancer Diagnostic Testing Market Drivers

Table 13. Melanoma Skin Cancer Diagnostic Testing Market Challenges

Table 14. Melanoma Skin Cancer Diagnostic Testing Market Restraints

Table 15. Global Melanoma Skin Cancer Diagnostic Testing Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Players (2019-2024)

Table 17. Global Top Melanoma Skin Cancer Diagnostic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Skin Cancer Diagnostic Testing as of 2023)

Table 18. Global Melanoma Skin Cancer Diagnostic Testing Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Melanoma Skin Cancer Diagnostic Testing Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Headquarters and Area Served

Table 21. Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Product and Application

Table 22. Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Type (2019-2024)

Table 26. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Type (2025-2030)

Table 28. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Application (2019-2024)

Table 30. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Application (2025-2030)

Table 32. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Melanoma Skin Cancer Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Melanoma Skin Cancer Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Melanoma Skin Cancer Diagnostic Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 64. Myriad Genetics Company Details

Table 65. Myriad Genetics Business Overview

Table 66. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Product

Table 67. Myriad Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 68. Myriad Genetics Recent Developments

Table 69. Abbott Laboratories Company Details

Table 70. Abbott Laboratories Business Overview

Table 71. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Product

Table 72. Abbott Laboratories Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 73. Abbott Laboratories Recent Developments

Table 74. Foundation Medicine Company Details

Table 75. Foundation Medicine Business Overview

Table 76. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Product

Table 77. Foundation Medicine Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 78. Foundation Medicine Recent Developments

Table 79. Pathway Genomics Corporation Company Details

Table 80. Pathway Genomics Corporation Business Overview

Table 81. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Product

Table 82. Pathway Genomics Corporation Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 83. Pathway Genomics Corporation Recent Developments

Table 84. Cancer Genetics Company Details

Table 85. Cancer Genetics Business Overview

Table 86. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Product

Table 87. Cancer Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 88. Cancer Genetics Recent Developments

Table 89. Castle Biosciences Company Details

Table 90. Castle Biosciences Business Overview

Table 91. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Product

Table 92. Castle Biosciences Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 93. Castle Biosciences Recent Developments

Table 94. NeoGenomics Company Details

Table 95. NeoGenomics Business Overview

Table 96. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Product

Table 97. NeoGenomics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 98. NeoGenomics Recent Developments

Table 99. Dermtech Company Details

Table 100. Dermtech Business Overview

Table 101. Dermtech Melanoma Skin Cancer Diagnostic Testing Product

Table 102. Dermtech Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 103. Dermtech Recent Developments

Table 104. Sysmex Inostics Company Details

Table 105. Sysmex Inostics Business Overview

Table 106. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Product

Table 107. Sysmex Inostics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 108. Sysmex Inostics Recent Developments

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Type: 2023 VS 2030

Figure 3. Biopsy Features

Figure 4. Imaging Features

Figure 5. Others Features

Figure 6. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Dermatology Clinics Case Studies

Figure 10. Diagnostic Laboratories Case Studies

Figure 11. Others Case Studies

Figure 12. Melanoma Skin Cancer Diagnostic Testing Report Years Considered

Figure 13. Global Melanoma Skin Cancer Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Melanoma Skin Cancer Diagnostic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region: 2023 VS 2030

Figure 16. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Players in 2023

Figure 17. Global Top Melanoma Skin Cancer Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Skin Cancer Diagnostic Testing as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Melanoma Skin Cancer Diagnostic Testing Revenue in 2023

Figure 19. North America Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2019-2030)

Figure 21. North America Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2019-2030)

Figure 22. North America Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2019-2030)

Figure 23. United States Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Melanoma Skin Cancer Diagnostic Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2019-2030)

Figure 27. Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2019-2030)

Figure 28. Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2019-2030)

Figure 29. Germany Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Melanoma Skin Cancer Diagnostic Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2019-2030)

Figure 37. China Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2019-2030)

Figure 38. Asia Melanoma Skin Cancer Diagnostic Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2019-2030)

Figure 40. Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2019-2030)

Figure 41. Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2019-2030)

Figure 42. Japan Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2019-2030)

Figure 52. Brazil Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Myriad Genetics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

Figure 59. Abbott Laboratories Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

Figure 60. Foundation Medicine Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

Figure 61. Pathway Genomics Corporation Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

Figure 62. Cancer Genetics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

Figure 63. Castle Biosciences Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

Figure 64. NeoGenomics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

Figure 65. Dermtech Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

Figure 66. Sysmex Inostics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions